“…We were the first group to establish a notable connection between the gut microbiome and GWI pathology, where we showed that the administration of Gulf War chemicals (GWC) in a mice model caused an alteration of the gut bacteriome signature, which in turn led to increased intestinal inflammation, gut leaching, endotoxemia, and release of the damage-associated molecular pattern (DAMP) HMGB1 (High motility group box 1) [ 6 , 7 ]. Subsequently, we have shown that GWI-associated dysbiosis in mice resulted in a decrease of the probiotic butyrogenic bacteria [ 7 , 8 ], increased Firmicutes abundance over Bacteroidetes in the phylum level [ 6 , 7 ], and a decrease of the probiotic species Akkermansia muciniphila [ 9 ] and these alterations attributed to increased intestinal inflammation, gut leaching [ 7 , 8 , 10 , 11 ], enteric glial cell activation [ 12 ], hepatic metabolic reprogramming [ 8 , 11 ], neuronal inflammation [ 6 , 7 , 9 , 10 ], the systemic release of HMGB1 [ 7 , 8 ], symptoms all of which fall under GWI pathology domain. We have also shown that administration of oral butyrate and the nutraceutical Sparstolonin B in mice helped to restore normal bacteriome patterns and decreased GWI-associated symptoms as described previously.…”